|
Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
Susan
D
Rountree,
Wenyaw
Chan,
Valory
N
Pavlik,
Eveleen
J
Darby,
Samina
Siddiqui,
Rachelle
S
Doody
Alzheimer's Research & Therapy 2009, 1:7 (21 October 2009)
Abstract
| Full text | PDF | PubMed |
Editor’s summary
Persistent treatment with cholinesterase inhibitors and/or memantine had a positive impact on Alzheimers disease (AD) progression by multiple cognitive and functional outcome measures.
|